U.S. market Closed. Opens in 17 hours 16 minutes

AMGN | Amgen Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for AMGN we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is poor, Growth is very bad and Health is very weak.

Valuation (50%)

Company Industry
P/E Ratio (TTM) 56.63 48.27
PEG Ratio (TTM) 11.66 5.21
P/S Ratio (TTM) 5.75 9.23
P/B Ratio (TTM) 29.91 26.30
P/FCF Ratio (TTM) 32.36 -50.04
Price to 5YR AVG Earnings Ratio 27.31 62.73
Price to 5YR AVG FCF Ratio 20.65 96.25

Profitability (50%)

Company Industry
ROA (TTM) 3.44% 8.52%
ROE (TTM) 50.41% 36.23%
Net Profit Margin (TTM) 10.15% 17.02%
ROIC 5YR AVG 17.66% 20.80%

Growth (38%)

4QTR AVG 3YR AVG 5YR AVG
EPS 154.17% -6.30% 0.41%
Revenue 5.11% 3.13% 3.56%
Net Income 153.81% -10.94% -3.82%
Cash Flow 42.91% -5.35% -4.79%

Health (33%)

Company Industry
Current Ratio (TTM) 1.26 1.10
Quick Ratio (TTM) 0.89 0.87
D/E Ratio (TTM) 10.57 2.87
Interest Coverage (TTM) 1.89 13.86
Piotroski F-Score 6 6
Altman Z-Score 1.49 5.00
LTL to 5YR AVG FCF 7.35 4.11
Shares Outstanding Growth 5YR AVG -4.10% 1.15%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙